Pancreatic Cancer Research

ResearcherGuangzhou Medical UniversityNo recent work listed

Xiaomin Li

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-0051-3354; OpenAlex author ID A5100422226. Sources: OpenAlex.

Their work

Papers
4 (first author 1, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
4
Papers, trials and grants by year

2021: 2 papers · 2022: 2 papers

Papers 4

  1. Unexpected favorable outcome to sintilimab monotherapy in a relapse pancreatic ductal adenocarcinoma patient with high tumor mutational burden: a case report. First author DOI 10.1097/cad.0000000000001334↗
  2. Corrigendum: Prognostic values and clinical significance of S100 family member's individualized mRNA expression in pancreatic adenocarcinoma. Co-author DOI 10.3389/fgene.2022.1057431↗
  3. Prognostic Values and Clinical Significance of S100 Family Member's Individualized mRNA Expression in Pancreatic Adenocarcinoma. Co-author DOI 10.3389/fgene.2021.758725↗
  4. Corrigendum: Prognostic Values and Clinical Significance of S100 Family Member's Individualized mRNA Expression in Pancreatic Adenocarcinoma. Co-author DOI 10.3389/fgene.2021.838600↗

Closest collaborators

The 4 strongest of 4 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Qijuan Li · 2 shared papers, 2021 · strength 0.44
  2. Qijuan Li · 1 shared paper, 2022 · strength 0.26
  3. Yibing Liu · 1 shared paper, 2022 · strength 0.15
  4. Fan Zhang · 1 shared paper, 2022 · strength 0.15

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.